胶质母细胞瘤 临床试验结果
-
Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma
-
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
-
TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid T
-
Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
-
Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma
-
A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Gl
-
Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma With
-
Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
-
Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Muta
-
Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma
-
Tofacitinib in Recurrent GBM Patients
-
Phase I Study of APX005M in Pediatric Central Nervous System Tumors
-
Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma
-
Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma
-
Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients Wit
按适应症浏览
肺癌非小细胞肺癌乳腺癌结直肠癌胃癌肝癌胰腺癌前列腺癌卵巢癌黑色素瘤白血病淋巴瘤多发性骨髓瘤胶质母细胞瘤2型糖尿病肥胖症高血压心力衰竭心房颤动脑卒中慢性肾病非酒精性脂肪性肝炎阿尔茨海默病帕金森病多发性硬化症抑郁症癫痫渐冻症类风湿关节炎银屑病特应性皮炎克罗恩病溃疡性结肠炎系统性红斑狼疮哮喘慢阻肺